Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Claudin 2 antibody (AA 29-81) (Biotin)

This anti-Claudin 2 antibody is a Rabbit Polyclonal antibody detecting Claudin 2 in ELISA. Suitable for Human.
Catalog No. ABIN7147900

Quick Overview for Claudin 2 antibody (AA 29-81) (Biotin) (ABIN7147900)

Target

See all Claudin 2 (CLDN2) Antibodies
Claudin 2 (CLDN2)

Reactivity

  • 86
  • 23
  • 17
  • 8
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 87
  • 4
Rabbit

Clonality

  • 85
  • 6
Polyclonal

Conjugate

  • 45
  • 8
  • 7
  • 7
  • 7
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This Claudin 2 antibody is conjugated to Biotin

Application

  • 64
  • 50
  • 43
  • 23
  • 9
  • 9
  • 8
  • 7
  • 4
  • 1
  • 1
ELISA
  • Binding Specificity

    • 16
    • 10
    • 9
    • 8
    • 7
    • 7
    • 6
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 29-81

    Cross-Reactivity

    Human

    Purification

    >95%, Protein G purified

    Immunogen

    Recombinant Human Claudin-20 protein (29-81AA)

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    Claudin 2 (CLDN2)

    Alternative Name

    CLDN2

    Background

    Background: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.

    Aliases: Claudin-20 antibody, CLD20_HUMAN antibody, CLDN20 antibody

    UniProt

    P56880

    Pathways

    Hepatitis C
You are here:
Chat with us!